Globalization Headache, U.K. Green Woes, Fragile U.S.: Eco Day
(Bloomberg) -- Welcome to Tuesday, Europe. Here's the latest news and analysis from Bloomberg Economics to help you start the day:
- Once known as the world's pharmacy, Germany now must work out how to supply medicine to its own citizens
- The Bank of England's stimulus plans, which juice polluting industries, run up against the U.K. government's green recovery pledge, a think tank said
- Boris Johnson's government will invest nearly 1.3 billion pounds ($1.7 billion) in building projects and provide 2 billion pounds in energy efficiency grants to create jobs and rally the U.K. economy
- From New York to Tel Aviv, the telecommuting revolution has meant a lot more work, according to an international study of 3.1 million people
- A fragile U.S. economy is in further trouble with government aid in limbo. At least economic data caught a break, with manufacturing expanding at its fastest pace since March 2019
- The Federal Reserve and other central banks are heading for a collision with shadow lenders -- the firms with a sinister nickname that increasingly dominate global finance
- Turkish inflation is likely to stall in a report Tuesday, with a fresh round of currency depreciation threatening to fuel more price pressures
- Australia's central bank kept its interest rate and yield target unchanged Tuesday while announcing it will end a three-month hiatus in bond buying, as Victoria state's tighter and longer lockdown adds to headwinds
- Brazil's economic team is considering extending emergency payments to informal workers past September, when they were due to expire, according to two people with direct knowledge of the matter
©2020 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.